Cas 706791-98-2,3-benzyloxy-5-(1,1-dioxo-1/<sup>6</sup>-isothiazolidin-2-yl)benzoic acid methyl ester

706791-98-2

Post Buying Request

Basic information

Product Name: 3-benzyloxy-5-(1,1-dioxo-1/⁶-isothiazolidin-2-yl)benzoic acid methyl ester
Synonyms: 3-benzyloxy-5-(1,1-dioxo-1/⁶-isothiazolidin-2-yl)benzoic acid methyl ester
CAS NO:706791-98-2
Molecular Formula:
Molecular Weight: 361.419
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-benzyloxy-5-(1,1-dioxo-1/⁶-isothiazolidin-2-yl)benzoic acid methyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 3-benzyloxy-5-(1,1-dioxo-1/⁶-isothiazolidin-2-yl)benzoic acid methyl ester(706791-98-2)
EPA Substance Registry System: 3-benzyloxy-5-(1,1-dioxo-1/⁶-isothiazolidin-2-yl)benzoic acid methyl ester(706791-98-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 706791-98-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

706791-98-2 Suppliers

Recommended suppliers

706791-98-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 706791-98-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,6,7,9 and 1 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 706791-98:
(8*7)+(7*0)+(6*6)+(5*7)+(4*9)+(3*1)+(2*9)+(1*8)=192
192 % 10 = 2
So 706791-98-2 is a valid CAS Registry Number.

706791-98-2Upstream product

706792-07-6 3-benzyloxy-5-(3-chloropropane-1-sulfonylamino)benzoic acid methyl ester

706791-98-2Downstream Products

706791-96-0 3-(1,1-dioxo-1/⁶-isothiazolidin-2-yl)-5-hydroxybenzoic acid methyl ester

706791-98-2Relevant academic research and scientific papers

HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE

-

Page 31-32, (2010/02/07)

The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated-amyloid levels or-amyloid deposits, particularly Alzheimer's disease.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 706791-98-2